Search & Filter

The UK will witness an increase in COPD in the near future, with the corresponding therapy market demonstrating greater revenue growth as a result.

Results from the six month phase 3 AMPLIFY trial of 5,395 patients with acute venous thromboembolism (VTE), which included symptomatic deep vein thrombosis (DVT) and/or pulmonary embolism (PE), have recently been announced. 

Takeda Nycomed AS announced today that they have signed a short term extension to the Supply and Distribution agreement with Shire Pharmaceuticals Ireland Limited relating to the ownership and promotion of the Calcichew® portfolio in the UK and Ireland.

Continuing to live independently and in their own home is important for people in later life, yet a survey conducted by Age UK Personal Alarms has found that one fifth of over 65s  felt there is a lack of available information on independence aids for the home. 

With the easy availability of online booking, last-minute travel is increasingly common. With careful thought, adequate advice on health risks and vaccinations can still be made available, as Mike Townsend explains.

Rational pharmacological intervention is essential for optimising glycaemic control in patients with type 2 diabetes. Metformin is the recommended first line agent, but the progressive pathogenesis of type 2 diabetes generally dictates the need for concomitant use of other drugs. Here, Caroline Day discusses the options following metformin monotherapy.

Vaginal bleeding is a common presenting symptom in perimenopausal women. Post menopausal bleeding is not uncommon, but warrants rapid assessment because 8% of patients will have endometrial cancer.

Lower urinary tract symptoms arising as a consequence of/or associated with benign prostatic hyperplasia are a common occurrence in the ageing male that frequently impact upon quality of life.  

RS3PE is a rare syndrome affecting older people with distal symmetrical synovitis of hands and wrists with pitting oedema. It is a benign condition with good prognosis.         

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality in the UK and worldwide. It is estimated to cost the NHS over £800 million annually, with nearly 24,000 attributable deaths in 2010, making it the fourth biggest cause of years of life lost in the UK.

NICE has issued a Final Appraisal Determination (FAD) for the first-in-class type 2 diabetes drug dapagliflozin (Forxiga).

Dr Ahmad Moolla, Dr Nadia Khalid and Dr Tahseen Chowdhury look at some of the key considerations when managing fasting patients with Type 2 diabetes during Ramadan. (BJFM 1(1) 2013)

Harry Brown provides his personal selection and appraisal of five 'must-have' apps for the busy practitioner. He looks at the following apps : NICE BNF, NICE Guidance, BMJ iPad edition, Medscape and Read by QxMD. (BJFM 1(1) 2013)

Modern medicine sometimes involves a number of parties individually contributing to a single patient's care in the community. There is likely to be overlap in their activities and the differing groups of various healthcare professionals who are each providing patient input can add up to a significant quantity of people and resources.

A request for the 'morning after pill' presents the GP with the challenge of making appropriate decisions based on a number of criteria. Dr Louise Newson, a GP and specialist writer on women's health, explores the issues and the options faced when prescribing emergency contraception. [BJFM 1(1) 2013]